InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by JONAS JEFFREY M, Director. Insider active across 1 companies, notably Sage Therapeutics, Inc.. Cumulatively, 7 reports have been published. The latest transaction was disclosed on 27 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations7 total
€13,19230,944 shares@ €0.426380.7% of flow
Common Stock
SEC:0001562180-22-003565:0·
€1,5824,000 shares@ €0.39569.7% of flow
Common Stock
SEC:0001562180-22-001626:0·
€1,5824,000 shares@ €0.3956100.0% of flow
Common Stock
SEC:0001562180-22-001626·
010,000 shares0
Common Stock
SEC:0001562180-21-006597·
010,000 shares0
Common Stock
SEC:0001562180-21-006597:0·
010,000 shares0
Common Stock
SEC:0001562180-21-004340·
010,000 shares0
Common Stock
SEC:0001562180-21-004340:0·
7 of 7 declarations
About JONAS JEFFREY M
Jeffrey M. Jonas is the Chief Innovation Officer and a Board Member at Sage Therapeutics, Inc. He is responsible for leading innovation and research initiatives. His expertise is essential for developing new therapeutic solutions.
